Nuvation Bio (NUVB)
US Market

Nuvation Bio (NUVB) Financial Statements


Nuvation Bio Financial Overview

Nuvation Bio's market cap is currently ―. The company's EPS TTM is $-0.504; its P/E ratio is -4.79; Nuvation Bio is scheduled to report earnings on March 9, 2023, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -29.34M$ -37.87M$ -28.36M$ -29.80M$ -22.96M
EBITDA$ -29.28M$ -37.82M$ -28.32M$ -29.76M$ -22.89M
Net Income Common Stockholders$ -27.20M$ -34.86M$ -21.29M$ -25.13M$ -21.98M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 673.95M$ 703.80M$ 737.70M$ 765.39M$ 791.78M
Total Assets$ 686.49M$ 719.74M$ 751.80M$ 776.15M$ 797.79M
Total Debt$ 4.47M$ 4.69M$ 2.79M$ 3.06M$ 0.00
Net Debt$ -669.47M$ -699.10M$ -734.92M$ -762.34M$ -791.78M
Total Liabilities$ 18.55M$ 26.66M$ 28.24M$ 30.15M$ 28.43M
Stockholders Equity$ 667.93M$ 693.08M$ 723.56M$ 746.00M$ 769.37M
Cash Flow
Free Cash Flow$ -28.20M$ -27.11M$ -24.94M$ -23.62M$ -13.18M
Operating Cash Flow$ -28.09M$ -26.92M$ -24.93M$ -23.48M$ -13.15M
Investing Cash Flow$ 64.20M$ 26.63M$ -5.55M$ -189.26M$ -91.72M
Financing Cash Flow$ 258.00K$ -3.60M$ 4.26M$ 538.00K$ -32.00K
Currency in USD

Nuvation Bio Earnings and Revenue History

Nuvation Bio Debt to Assets

Nuvation Bio Cash Flow

Nuvation Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis